Morristown, NJ –July 14, 2005–CSSC, a regulatory compliance and validation company, expands its global presence by partnering with ADN. CSSC and ADN, both leading providers of regulatory compliance solutions to the life sciences industry, announced today a strategic partnership. CSSC, headquartered in Morristown, New Jersey, USA and ADN, based in Paris, France, provide comprehensive global services to help pharmaceutical, medical device and biotech companies stay compliant in a challenging regulatory environment.
“This partnership with ADN strengthens our presence in Europe,” said Raymond A. Roggero, president and chief operating officer, CSSC. “In today’s global economy, we are prepared to meet the needs of our international clients, especially those with major operations in the United States, France and UK.”
“CSSC and ADN decided to enter into a strategic alliance because our expertise and services complement each other and the partnership will benefit our clients,” said Philippe Baron, president, ADN.
About CSSC, Inc.
CSSC, Inc., headquartered in Morristown, New Jersey, USA, provides full-service regulatory compliance services and consulting. Founded in 1994, CSSC offers a complete range of compliance solutions to the pharmaceutical, biotechnology, and medical device industries, including comprehensive validation services, project management, Quality System Regulation consulting, 21 CFR Part 11 services, PDMA compliance solutions, auditing, and training. For more information, visit www.csscinc.net.
ADN, headquartered in Paris, France, provides IT and regulation expertise for the life sciences industry. Since 1993, ADN has been a specialist in providing computer systems validation services and regulatory compliance consulting services to the pharmaceutical industry relating to bio-specialties and medical devices. More than 40 consultants in 3 offices in France and UK address specific requirements in the fields of Research and Development, Production, Industrial Management and Clinical Trials. For more information, visit www.adneurope.com.